Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed.

Many of us are dry eye sufferers, especially in the cooler months, but not everyone has to live with red-eyed irritation. We ...

Retinitis pigmentosa (RP) is a rare inherited condition that causes the gradual death of photoreceptors (light-sensing cells) ...

A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...

Researchers have developed a groundbreaking eye drop treatment that slows vision loss in animal models of retinitis ...

You should avoid taking expired medication because it may become toxic, contain bacteria, or be less effective.

Surrozen is discontinuing its sole clinical-stage candidate and pivoting to its preclinical ophthalmology pipeline after the ...

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.